Enhanced Radiosensitization Effect of Curcumin Delivered by PVP-PCL Nanoparticle in Lung Cancer

Abstract EN

Curcumin, the principal polyphenolic curcuminoid, has been reported in numerous studies for its antitumor effect in a series of cancers.

It is also reported that curcumin possesses radiosensitization effect in some cancers.

However, the poor solubility and unsatisfied bioavailability of curcumin significantly undermine its potential application.

Here we prepared curcumin loaded nanoparticles by employing PVP-PCL as drug carrier.

Characterization studies indicated the satisfied drug loading efficiency and a sustained in vitro release pattern.

Quantification uptake study showed that the uptake efficiency of Cum-NPs by lung cancer cells was time- and dose-dependent.

In vitro anticancer study demonstrated the superior cytotoxic effect of Cum-NPs with stronger apoptotic induction over free Cum.

Most importantly, there is almost no report on the radiosensitization effect of curcumin loaded nanoparticles.

Here, Cum-NPs led to more inhibition of the colony forming ability of A549 cells as compared to the equivalent concentration of free Cum as shown in clonogenic assay.

Furthermore, Cum-NPs are much more effective in enhancing the tumor growth inhibitory effect of radiation therapy in a A549 xenograft model.

Therefore, results from the current study seem to be the first report on the radiosensitization effect of Cum-NPs and paved the way for a curcumin nanodrug delivery system as a potential radiation adjuvant.